| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caregivers | 61 | 2022 | 365 | 12.110 |
Why?
|
| Stress, Psychological | 27 | 2022 | 824 | 5.010 |
Why?
|
| Dementia | 15 | 2022 | 158 | 3.470 |
Why?
|
| Kidney Calculi | 8 | 2019 | 19 | 3.190 |
Why?
|
| Hypertension | 27 | 2022 | 1535 | 2.840 |
Why?
|
| Adaptation, Psychological | 15 | 2021 | 447 | 2.580 |
Why?
|
| Renal Insufficiency, Chronic | 14 | 2021 | 161 | 2.470 |
Why?
|
| Depression | 24 | 2022 | 943 | 2.380 |
Why?
|
| Social Support | 27 | 2023 | 423 | 2.290 |
Why?
|
| Aged | 115 | 2023 | 14862 | 2.250 |
Why?
|
| Quality of Life | 17 | 2021 | 1515 | 2.240 |
Why?
|
| Antihypertensive Agents | 18 | 2022 | 498 | 2.190 |
Why?
|
| Stroke | 21 | 2022 | 2163 | 2.160 |
Why?
|
| Blood Pressure | 17 | 2022 | 1451 | 1.870 |
Why?
|
| Hospice Care | 9 | 2019 | 29 | 1.820 |
Why?
|
| Survivors | 11 | 2019 | 256 | 1.620 |
Why?
|
| Humans | 156 | 2023 | 68618 | 1.590 |
Why?
|
| Guideline Adherence | 5 | 2021 | 287 | 1.520 |
Why?
|
| Practice Guidelines as Topic | 8 | 2021 | 772 | 1.490 |
Why?
|
| Female | 108 | 2022 | 38074 | 1.480 |
Why?
|
| Male | 101 | 2021 | 37321 | 1.390 |
Why?
|
| Aged, 80 and over | 52 | 2021 | 4848 | 1.330 |
Why?
|
| Family | 8 | 2023 | 293 | 1.330 |
Why?
|
| Personal Satisfaction | 8 | 2020 | 123 | 1.310 |
Why?
|
| Mental Health | 5 | 2023 | 278 | 1.300 |
Why?
|
| Cognitive Dysfunction | 4 | 2021 | 176 | 1.260 |
Why?
|
| Middle Aged | 66 | 2023 | 21147 | 1.250 |
Why?
|
| Nephrology | 5 | 2014 | 43 | 1.250 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2019 | 2324 | 1.220 |
Why?
|
| Bereavement | 8 | 2019 | 39 | 1.210 |
Why?
|
| Activities of Daily Living | 10 | 2017 | 319 | 1.200 |
Why?
|
| Health Status | 5 | 2020 | 429 | 1.180 |
Why?
|
| Spouses | 8 | 2020 | 51 | 1.160 |
Why?
|
| Cost of Illness | 6 | 2015 | 206 | 1.040 |
Why?
|
| Memory, Episodic | 2 | 2022 | 10 | 1.020 |
Why?
|
| Alzheimer Disease | 12 | 2014 | 565 | 1.020 |
Why?
|
| Geriatrics | 5 | 2012 | 69 | 1.010 |
Why?
|
| Kidney Failure, Chronic | 6 | 2019 | 365 | 1.000 |
Why?
|
| United States | 30 | 2022 | 7367 | 0.970 |
Why?
|
| Emotions | 6 | 2021 | 244 | 0.960 |
Why?
|
| Glomerular Filtration Rate | 11 | 2021 | 274 | 0.950 |
Why?
|
| Self Report | 5 | 2020 | 371 | 0.920 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2019 | 468 | 0.920 |
Why?
|
| Disabled Persons | 5 | 2021 | 94 | 0.890 |
Why?
|
| Health Status Indicators | 5 | 2018 | 117 | 0.880 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2021 | 504 | 0.860 |
Why?
|
| Carotid Stenosis | 2 | 2021 | 163 | 0.850 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 5 | 2019 | 89 | 0.840 |
Why?
|
| Advance Directives | 2 | 2021 | 22 | 0.820 |
Why?
|
| Medicare | 7 | 2021 | 319 | 0.820 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2021 | 53 | 0.770 |
Why?
|
| Phantoms, Imaging | 4 | 2015 | 189 | 0.760 |
Why?
|
| Counseling | 5 | 2011 | 280 | 0.760 |
Why?
|
| Arthritis | 2 | 2013 | 53 | 0.730 |
Why?
|
| Emigrants and Immigrants | 2 | 2018 | 45 | 0.730 |
Why?
|
| Cross-Sectional Studies | 15 | 2022 | 2279 | 0.720 |
Why?
|
| Nursing Homes | 8 | 2017 | 54 | 0.710 |
Why?
|
| Child Abuse, Sexual | 1 | 2021 | 150 | 0.710 |
Why?
|
| Death | 1 | 2020 | 38 | 0.710 |
Why?
|
| Terminal Care | 4 | 2020 | 92 | 0.710 |
Why?
|
| Hospices | 5 | 2019 | 14 | 0.710 |
Why?
|
| Cognition | 8 | 2022 | 513 | 0.680 |
Why?
|
| Albuminuria | 5 | 2020 | 171 | 0.670 |
Why?
|
| Kidney Tubules | 4 | 2020 | 80 | 0.670 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 2223 | 0.670 |
Why?
|
| Patient Care | 1 | 2019 | 61 | 0.660 |
Why?
|
| Disclosure | 1 | 2019 | 45 | 0.650 |
Why?
|
| Quality Assurance, Health Care | 2 | 2012 | 177 | 0.650 |
Why?
|
| Disease Management | 4 | 2020 | 248 | 0.640 |
Why?
|
| Workplace | 1 | 2019 | 75 | 0.640 |
Why?
|
| Stents | 2 | 2014 | 657 | 0.640 |
Why?
|
| Patient Participation | 1 | 2019 | 146 | 0.620 |
Why?
|
| Aging | 4 | 2021 | 911 | 0.600 |
Why?
|
| Kidney Diseases | 3 | 2020 | 307 | 0.600 |
Why?
|
| Independent Living | 1 | 2017 | 44 | 0.570 |
Why?
|
| Neoplasms | 8 | 2013 | 1667 | 0.570 |
Why?
|
| Self-Help Groups | 4 | 2011 | 38 | 0.570 |
Why?
|
| Florida | 11 | 2016 | 221 | 0.550 |
Why?
|
| Breast Neoplasms | 4 | 2019 | 1536 | 0.540 |
Why?
|
| Social Participation | 3 | 2021 | 16 | 0.530 |
Why?
|
| Prospective Studies | 12 | 2020 | 3705 | 0.530 |
Why?
|
| Kidney | 2 | 2020 | 945 | 0.520 |
Why?
|
| Attitude to Health | 6 | 2013 | 403 | 0.510 |
Why?
|
| Artifacts | 1 | 2015 | 125 | 0.490 |
Why?
|
| Interdisciplinary Communication | 2 | 2014 | 93 | 0.480 |
Why?
|
| Risk Factors | 17 | 2022 | 5731 | 0.480 |
Why?
|
| Decision Making | 4 | 2006 | 410 | 0.480 |
Why?
|
| Medication Adherence | 2 | 2022 | 335 | 0.470 |
Why?
|
| Patient Care Management | 1 | 2014 | 40 | 0.470 |
Why?
|
| Widowhood | 2 | 2011 | 2 | 0.470 |
Why?
|
| Ureteral Calculi | 1 | 2014 | 4 | 0.470 |
Why?
|
| Evidence-Based Medicine | 4 | 2012 | 438 | 0.470 |
Why?
|
| Follow-Up Studies | 14 | 2020 | 3259 | 0.470 |
Why?
|
| Cognition Disorders | 5 | 2017 | 342 | 0.470 |
Why?
|
| Friends | 3 | 2023 | 33 | 0.460 |
Why?
|
| Diuretics | 2 | 2018 | 97 | 0.460 |
Why?
|
| HIV Infections | 1 | 2021 | 791 | 0.460 |
Why?
|
| Sex Factors | 10 | 2019 | 1266 | 0.450 |
Why?
|
| Universities | 3 | 2012 | 191 | 0.440 |
Why?
|
| Renal Replacement Therapy | 2 | 2003 | 40 | 0.440 |
Why?
|
| Depressive Disorder | 6 | 2011 | 621 | 0.440 |
Why?
|
| Longitudinal Studies | 9 | 2022 | 1054 | 0.440 |
Why?
|
| Ureter | 1 | 2012 | 16 | 0.420 |
Why?
|
| Cross-Cultural Comparison | 3 | 2017 | 68 | 0.420 |
Why?
|
| Patient Preference | 1 | 2013 | 57 | 0.410 |
Why?
|
| Urologic Surgical Procedures | 1 | 2012 | 47 | 0.410 |
Why?
|
| Time Factors | 14 | 2020 | 4655 | 0.400 |
Why?
|
| Brain Ischemia | 2 | 2019 | 665 | 0.390 |
Why?
|
| Accreditation | 1 | 2012 | 72 | 0.390 |
Why?
|
| Geriatric Assessment | 4 | 2007 | 107 | 0.390 |
Why?
|
| Inflammation | 4 | 2022 | 1030 | 0.390 |
Why?
|
| Professional Competence | 1 | 2012 | 100 | 0.380 |
Why?
|
| Hypotension, Orthostatic | 3 | 2020 | 15 | 0.380 |
Why?
|
| Comorbidity | 8 | 2020 | 1426 | 0.380 |
Why?
|
| Blood Pressure Determination | 7 | 2020 | 152 | 0.370 |
Why?
|
| Marriage | 1 | 2011 | 30 | 0.370 |
Why?
|
| Osteoarthritis | 2 | 2013 | 73 | 0.370 |
Why?
|
| Acute Kidney Injury | 3 | 2019 | 232 | 0.370 |
Why?
|
| Personality | 2 | 2008 | 66 | 0.360 |
Why?
|
| Quality Improvement | 1 | 2014 | 413 | 0.360 |
Why?
|
| Parents | 2 | 2010 | 312 | 0.350 |
Why?
|
| Age Factors | 7 | 2019 | 1864 | 0.350 |
Why?
|
| Intellectual Disability | 1 | 2010 | 114 | 0.340 |
Why?
|
| White Coat Hypertension | 2 | 2019 | 4 | 0.340 |
Why?
|
| Masked Hypertension | 2 | 2019 | 7 | 0.340 |
Why?
|
| Case-Control Studies | 4 | 2020 | 1553 | 0.330 |
Why?
|
| Primary Health Care | 1 | 2014 | 703 | 0.320 |
Why?
|
| Total Quality Management | 2 | 2006 | 45 | 0.320 |
Why?
|
| Thiazides | 1 | 2008 | 6 | 0.320 |
Why?
|
| Institutionalization | 2 | 2008 | 7 | 0.320 |
Why?
|
| Health Services Needs and Demand | 3 | 2011 | 149 | 0.310 |
Why?
|
| Loneliness | 2 | 2022 | 20 | 0.310 |
Why?
|
| Myocardial Infarction | 5 | 2022 | 807 | 0.310 |
Why?
|
| Coronary Disease | 1 | 2010 | 358 | 0.300 |
Why?
|
| Case Management | 1 | 2008 | 46 | 0.300 |
Why?
|
| Adult | 21 | 2020 | 21403 | 0.290 |
Why?
|
| Socioeconomic Factors | 6 | 2019 | 955 | 0.290 |
Why?
|
| Minority Groups | 1 | 2008 | 197 | 0.280 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 940 | 0.280 |
Why?
|
| Education, Graduate | 1 | 2007 | 30 | 0.280 |
Why?
|
| Systole | 5 | 2018 | 149 | 0.280 |
Why?
|
| Family Therapy | 1 | 2007 | 82 | 0.280 |
Why?
|
| Interpersonal Relations | 2 | 2022 | 209 | 0.270 |
Why?
|
| Persistent Vegetative State | 1 | 2006 | 5 | 0.270 |
Why?
|
| Mortality | 3 | 2018 | 163 | 0.270 |
Why?
|
| Treatment Outcome | 11 | 2021 | 7029 | 0.270 |
Why?
|
| Behavior Therapy | 1 | 2008 | 297 | 0.260 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 442 | 0.260 |
Why?
|
| Interviews as Topic | 5 | 2011 | 392 | 0.260 |
Why?
|
| Advance Care Planning | 1 | 2005 | 11 | 0.260 |
Why?
|
| Health Surveys | 5 | 2017 | 489 | 0.260 |
Why?
|
| Risk Assessment | 6 | 2020 | 2007 | 0.260 |
Why?
|
| Surveys and Questionnaires | 7 | 2023 | 2800 | 0.250 |
Why?
|
| Attitude to Death | 5 | 2011 | 52 | 0.250 |
Why?
|
| Social Isolation | 3 | 2020 | 40 | 0.240 |
Why?
|
| Asymptomatic Diseases | 2 | 2021 | 43 | 0.240 |
Why?
|
| Regression Analysis | 5 | 2013 | 737 | 0.240 |
Why?
|
| Chronic Disease | 7 | 2012 | 1330 | 0.240 |
Why?
|
| Disease Progression | 5 | 2020 | 1038 | 0.240 |
Why?
|
| Logistic Models | 5 | 2018 | 1420 | 0.230 |
Why?
|
| Psychotherapy | 2 | 2005 | 253 | 0.230 |
Why?
|
| Models, Psychological | 2 | 2011 | 180 | 0.220 |
Why?
|
| Life Style | 2 | 2020 | 338 | 0.220 |
Why?
|
| Chitinase-3-Like Protein 1 | 2 | 2020 | 3 | 0.220 |
Why?
|
| Interleukin-18 | 2 | 2020 | 16 | 0.220 |
Why?
|
| Psychometrics | 2 | 2019 | 514 | 0.220 |
Why?
|
| Suicide, Assisted | 1 | 2002 | 14 | 0.220 |
Why?
|
| Eligibility Determination | 1 | 2003 | 31 | 0.220 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 1851 | 0.210 |
Why?
|
| Telomere Shortening | 1 | 2022 | 8 | 0.210 |
Why?
|
| Biomarkers | 7 | 2022 | 1593 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 767 | 0.210 |
Why?
|
| Social Networking | 1 | 2022 | 14 | 0.200 |
Why?
|
| Creatinine | 3 | 2020 | 243 | 0.200 |
Why?
|
| New York | 4 | 2013 | 223 | 0.200 |
Why?
|
| Audiology | 1 | 2021 | 8 | 0.200 |
Why?
|
| Incidence | 4 | 2020 | 1603 | 0.200 |
Why?
|
| Spain | 1 | 2021 | 34 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 180 | 0.190 |
Why?
|
| North America | 1 | 2021 | 112 | 0.190 |
Why?
|
| Affect | 2 | 2015 | 218 | 0.190 |
Why?
|
| Writing | 1 | 2021 | 29 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 931 | 0.190 |
Why?
|
| Cause of Death | 3 | 2017 | 241 | 0.190 |
Why?
|
| Memory | 2 | 2015 | 214 | 0.190 |
Why?
|
| Drug Utilization | 1 | 2021 | 119 | 0.190 |
Why?
|
| Acute Coronary Syndrome | 3 | 2017 | 195 | 0.190 |
Why?
|
| White Matter | 2 | 2021 | 174 | 0.180 |
Why?
|
| Sexual Behavior | 1 | 2021 | 183 | 0.180 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 83 | 0.180 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Research Design | 2 | 2021 | 729 | 0.180 |
Why?
|
| Cohort Studies | 6 | 2022 | 2358 | 0.170 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 125 | 0.170 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 135 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2077 | 0.170 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 101 | 0.170 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 649 | 0.170 |
Why?
|
| Reference Standards | 2 | 2017 | 115 | 0.170 |
Why?
|
| Patient Selection | 1 | 2003 | 592 | 0.160 |
Why?
|
| Students | 1 | 2021 | 233 | 0.160 |
Why?
|
| Sampling Studies | 1 | 2018 | 80 | 0.160 |
Why?
|
| Life Change Events | 2 | 2015 | 223 | 0.160 |
Why?
|
| Models, Educational | 2 | 2012 | 67 | 0.160 |
Why?
|
| Sex Characteristics | 2 | 2011 | 295 | 0.150 |
Why?
|
| Information Systems | 2 | 2008 | 45 | 0.150 |
Why?
|
| Curriculum | 4 | 2012 | 575 | 0.150 |
Why?
|
| Renal Dialysis | 1 | 2019 | 174 | 0.150 |
Why?
|
| Employment | 1 | 2019 | 154 | 0.150 |
Why?
|
| Social Work | 2 | 2012 | 27 | 0.150 |
Why?
|
| Hospitalization | 3 | 2016 | 978 | 0.150 |
Why?
|
| Marital Status | 1 | 2017 | 65 | 0.150 |
Why?
|
| Referral and Consultation | 2 | 2014 | 383 | 0.150 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 138 | 0.150 |
Why?
|
| Telephone | 2 | 2009 | 160 | 0.150 |
Why?
|
| Quality of Health Care | 1 | 2020 | 322 | 0.150 |
Why?
|
| Cultural Diversity | 2 | 2008 | 67 | 0.140 |
Why?
|
| Health Services Accessibility | 3 | 2018 | 581 | 0.140 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 202 | 0.140 |
Why?
|
| Cystatin C | 1 | 2016 | 3 | 0.140 |
Why?
|
| Perception | 2 | 2008 | 189 | 0.140 |
Why?
|
| Triiodobenzoic Acids | 1 | 2016 | 28 | 0.140 |
Why?
|
| Family Relations | 2 | 2006 | 47 | 0.140 |
Why?
|
| Posture | 1 | 2016 | 107 | 0.130 |
Why?
|
| Iohexol | 1 | 2016 | 82 | 0.130 |
Why?
|
| Social Perception | 2 | 2007 | 44 | 0.130 |
Why?
|
| Home Nursing | 2 | 2006 | 8 | 0.130 |
Why?
|
| Proportional Hazards Models | 4 | 2020 | 792 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 32 | 0.130 |
Why?
|
| Motion | 1 | 2015 | 24 | 0.130 |
Why?
|
| Sick Role | 2 | 2007 | 40 | 0.130 |
Why?
|
| Analysis of Variance | 4 | 2013 | 1040 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2017 | 191 | 0.130 |
Why?
|
| Reference Values | 1 | 2016 | 579 | 0.130 |
Why?
|
| Outpatients | 1 | 2016 | 127 | 0.130 |
Why?
|
| Statistics as Topic | 2 | 2017 | 219 | 0.120 |
Why?
|
| South Carolina | 1 | 2021 | 2752 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 121 | 0.120 |
Why?
|
| Nephrolithiasis | 1 | 2014 | 9 | 0.120 |
Why?
|
| Sex Distribution | 3 | 2010 | 274 | 0.120 |
Why?
|
| Urinary Calculi | 1 | 2014 | 4 | 0.120 |
Why?
|
| Retrospective Studies | 7 | 2014 | 7277 | 0.120 |
Why?
|
| Skilled Nursing Facilities | 1 | 2014 | 30 | 0.120 |
Why?
|
| Speech-Language Pathology | 1 | 2014 | 24 | 0.120 |
Why?
|
| Mental Recall | 1 | 2014 | 72 | 0.120 |
Why?
|
| Korea | 2 | 2013 | 13 | 0.120 |
Why?
|
| Prevalence | 1 | 2018 | 1619 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2015 | 111 | 0.120 |
Why?
|
| Sepharose | 1 | 2014 | 18 | 0.120 |
Why?
|
| Physicians | 2 | 2014 | 324 | 0.120 |
Why?
|
| Uric Acid | 1 | 2014 | 37 | 0.110 |
Why?
|
| Swine | 1 | 2015 | 672 | 0.110 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 225 | 0.110 |
Why?
|
| Heart Failure | 3 | 2017 | 1180 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 782 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2015 | 285 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 146 | 0.110 |
Why?
|
| Community Health Planning | 1 | 2013 | 19 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 90 | 0.110 |
Why?
|
| Negotiating | 1 | 2013 | 18 | 0.110 |
Why?
|
| Length of Stay | 1 | 2016 | 780 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2014 | 249 | 0.110 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 517 | 0.110 |
Why?
|
| Resilience, Psychological | 2 | 2013 | 43 | 0.100 |
Why?
|
| Smoking | 1 | 2020 | 1452 | 0.100 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 33 | 0.100 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2012 | 15 | 0.100 |
Why?
|
| Social Identification | 1 | 2012 | 12 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 333 | 0.100 |
Why?
|
| Urolithiasis | 1 | 2011 | 1 | 0.100 |
Why?
|
| Calcium Oxalate | 1 | 2011 | 2 | 0.100 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2011 | 2 | 0.100 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2011 | 3 | 0.100 |
Why?
|
| Geriatric Nursing | 1 | 2012 | 35 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2014 | 419 | 0.100 |
Why?
|
| Stroke Rehabilitation | 2 | 2013 | 335 | 0.100 |
Why?
|
| Internationality | 1 | 2012 | 74 | 0.100 |
Why?
|
| Europe | 1 | 2012 | 196 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2012 | 87 | 0.100 |
Why?
|
| Patient Care Planning | 2 | 2019 | 108 | 0.100 |
Why?
|
| Home Care Services | 2 | 2010 | 84 | 0.100 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2011 | 5 | 0.100 |
Why?
|
| Ureteroscopy | 1 | 2011 | 5 | 0.090 |
Why?
|
| Time Management | 1 | 2011 | 12 | 0.090 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 839 | 0.090 |
Why?
|
| Leisure Activities | 1 | 2011 | 22 | 0.090 |
Why?
|
| Lithotripsy | 1 | 2011 | 18 | 0.090 |
Why?
|
| Residential Facilities | 1 | 2010 | 5 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 81 | 0.090 |
Why?
|
| Educational Status | 1 | 2012 | 273 | 0.090 |
Why?
|
| Risk | 3 | 2020 | 563 | 0.090 |
Why?
|
| Child | 1 | 2021 | 6405 | 0.090 |
Why?
|
| Pain | 2 | 2002 | 472 | 0.090 |
Why?
|
| Program Evaluation | 3 | 2007 | 502 | 0.090 |
Why?
|
| Uromodulin | 2 | 2020 | 3 | 0.090 |
Why?
|
| Alpha-Globulins | 2 | 2020 | 18 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 296 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 1465 | 0.090 |
Why?
|
| Parenting | 1 | 2010 | 91 | 0.090 |
Why?
|
| Workload | 1 | 2010 | 103 | 0.090 |
Why?
|
| Pancreas | 1 | 2011 | 225 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 546 | 0.090 |
Why?
|
| Fecal Incontinence | 1 | 2009 | 6 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2010 | 239 | 0.080 |
Why?
|
| Prognosis | 3 | 2016 | 2093 | 0.080 |
Why?
|
| Choice Behavior | 1 | 2009 | 85 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2008 | 51 | 0.080 |
Why?
|
| Language | 1 | 2009 | 120 | 0.080 |
Why?
|
| Organizational Case Studies | 1 | 2008 | 53 | 0.080 |
Why?
|
| Directive Counseling | 1 | 2008 | 23 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 786 | 0.080 |
Why?
|
| Models, Animal | 1 | 2008 | 252 | 0.070 |
Why?
|
| Psychotherapy, Group | 1 | 2007 | 55 | 0.070 |
Why?
|
| Helping Behavior | 1 | 2006 | 4 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2008 | 136 | 0.070 |
Why?
|
| Anxiety | 1 | 2010 | 422 | 0.070 |
Why?
|
| Program Development | 1 | 2008 | 240 | 0.070 |
Why?
|
| Legal Guardians | 1 | 2006 | 3 | 0.070 |
Why?
|
| Right to Die | 1 | 2006 | 5 | 0.070 |
Why?
|
| Family Health | 1 | 2006 | 83 | 0.070 |
Why?
|
| Decision Trees | 1 | 2006 | 74 | 0.070 |
Why?
|
| Medicaid | 1 | 2008 | 302 | 0.060 |
Why?
|
| Family Practice | 1 | 2008 | 312 | 0.060 |
Why?
|
| Mental Status Schedule | 2 | 2003 | 31 | 0.060 |
Why?
|
| Psychology, Clinical | 1 | 2005 | 3 | 0.060 |
Why?
|
| Geriatric Psychiatry | 1 | 2005 | 9 | 0.060 |
Why?
|
| Animals | 2 | 2015 | 20881 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 951 | 0.060 |
Why?
|
| Professional Staff Committees | 1 | 2003 | 11 | 0.060 |
Why?
|
| Injections, Intravenous | 2 | 2016 | 215 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2007 | 622 | 0.060 |
Why?
|
| Fellowships and Scholarships | 1 | 2005 | 127 | 0.060 |
Why?
|
| Decision Making, Organizational | 1 | 2003 | 23 | 0.060 |
Why?
|
| Psychomotor Agitation | 1 | 2004 | 63 | 0.060 |
Why?
|
| Terminally Ill | 1 | 2003 | 17 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2003 | 60 | 0.050 |
Why?
|
| Attitude | 1 | 2004 | 121 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2003 | 193 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1745 | 0.050 |
Why?
|
| Professional Practice | 1 | 2003 | 47 | 0.050 |
Why?
|
| Nursing Staff | 1 | 2002 | 30 | 0.050 |
Why?
|
| Neurotic Disorders | 1 | 2002 | 13 | 0.050 |
Why?
|
| Hearing Disorders | 1 | 2002 | 23 | 0.050 |
Why?
|
| Telomere | 1 | 2022 | 59 | 0.050 |
Why?
|
| Bias | 1 | 2002 | 148 | 0.050 |
Why?
|
| Circadian Rhythm | 2 | 2012 | 218 | 0.050 |
Why?
|
| Perfusion | 1 | 2021 | 131 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2003 | 714 | 0.050 |
Why?
|
| beta 2-Microglobulin | 1 | 2020 | 15 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2022 | 652 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 425 | 0.040 |
Why?
|
| Rats | 1 | 2008 | 5300 | 0.040 |
Why?
|
| Urinalysis | 1 | 2020 | 27 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 521 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 1046 | 0.040 |
Why?
|
| Bradycardia | 1 | 2020 | 45 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 65 | 0.040 |
Why?
|
| Renal Reabsorption | 1 | 2019 | 1 | 0.040 |
Why?
|
| Hypotension | 1 | 2020 | 74 | 0.040 |
Why?
|
| Lipocalin-2 | 1 | 2019 | 19 | 0.040 |
Why?
|
| Grief | 1 | 2019 | 32 | 0.040 |
Why?
|
| Urban Population | 1 | 2020 | 255 | 0.040 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2017 | 11 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2017 | 31 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2017 | 32 | 0.040 |
Why?
|
| Diastole | 1 | 2017 | 161 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 114 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 948 | 0.030 |
Why?
|
| Body Height | 1 | 2016 | 67 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 567 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 1070 | 0.030 |
Why?
|
| Critical Care | 1 | 2017 | 263 | 0.030 |
Why?
|
| Oxalates | 1 | 2014 | 4 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2014 | 59 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 16 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2014 | 113 | 0.030 |
Why?
|
| Urology | 1 | 2014 | 31 | 0.030 |
Why?
|
| Comprehensive Health Care | 1 | 2014 | 26 | 0.030 |
Why?
|
| Adolescent | 1 | 2006 | 8912 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 330 | 0.030 |
Why?
|
| Professional-Family Relations | 1 | 2013 | 45 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 219 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2012 | 23 | 0.030 |
Why?
|
| Contrast Media | 1 | 2016 | 595 | 0.030 |
Why?
|
| Culture | 1 | 2013 | 75 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2012 | 96 | 0.030 |
Why?
|
| Cryoglobulinemia | 1 | 2012 | 5 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 237 | 0.030 |
Why?
|
| Social Behavior | 1 | 1993 | 164 | 0.030 |
Why?
|
| Rituximab | 1 | 2012 | 61 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 442 | 0.020 |
Why?
|
| Proteinuria | 1 | 2012 | 136 | 0.020 |
Why?
|
| Software | 1 | 2014 | 418 | 0.020 |
Why?
|
| Canada | 1 | 2012 | 267 | 0.020 |
Why?
|
| Amylases | 1 | 2011 | 17 | 0.020 |
Why?
|
| Lipase | 1 | 2011 | 16 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 689 | 0.020 |
Why?
|
| Self Care | 1 | 1993 | 253 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 2176 | 0.020 |
Why?
|
| Calcium | 1 | 2014 | 929 | 0.020 |
Why?
|
| Self Concept | 1 | 2010 | 132 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 320 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2004 | 1342 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2011 | 252 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.020 |
Why?
|
| Faculty | 1 | 2007 | 56 | 0.020 |
Why?
|
| Mutation | 1 | 2011 | 1213 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Fatigue | 1 | 2006 | 132 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2008 | 276 | 0.020 |
Why?
|
| Organizational Affiliation | 1 | 2005 | 8 | 0.020 |
Why?
|
| Public Health Administration | 1 | 2005 | 36 | 0.020 |
Why?
|
| New York City | 1 | 2004 | 49 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 2005 | 147 | 0.010 |
Why?
|
| Residential Treatment | 1 | 2004 | 24 | 0.010 |
Why?
|
| Schools, Medical | 1 | 2005 | 157 | 0.010 |
Why?
|
| Religion and Psychology | 1 | 2003 | 15 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 694 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2003 | 112 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 5717 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2002 | 328 | 0.010 |
Why?
|
| Health Personnel | 1 | 2004 | 286 | 0.010 |
Why?
|
| Pain Management | 1 | 2002 | 186 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2008 | 1173 | 0.010 |
Why?
|
| Personality Assessment | 1 | 1993 | 71 | 0.010 |
Why?
|
| Aggression | 1 | 1993 | 98 | 0.010 |
Why?
|
| Sleep Wake Disorders | 1 | 1993 | 94 | 0.010 |
Why?
|
| Communication | 1 | 1993 | 329 | 0.010 |
Why?
|